myBiometry key facts
as of Oct 2026- Developer of a remote-monitoring platform designed for respiratory disease management.
- myBiometry is valued at approximately $31.5M as of Oct 2026 (last reported valuation).
- It has raised $15.8M; the latest was Accelerator/Incubator ($50K) in Feb 2026.
- Notable investors include MassChallenge, MedTech Innovator, Matter (Consulting Services (B2B)), Elevate Ventures, New York Angels — 22 tracked in total.
- Status: Privately Held (backing).
myBiometry's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·The complete investor list: 22 names
- ·Watch myBiometry: the Monday email on marks, rounds and moves
myBiometry funding rounds
No funding rounds for myBiometry are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs myBiometry
22+myBiometry valuation
myBiometry's last reported valuation was $31.5 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
myBiometry investors
22 investors are on record for myBiometry, including MassChallenge, MedTech Innovator, Matter (Consulting Services (B2B)) and Elevate Ventures. By type, the record holds 4 angel investors and 1 venture capital firm.
About myBiometry
Developer of a remote-monitoring platform designed for respiratory disease management. The company's platform uses a patented sensor and breath-based biomarker measurement together with software that aggregates clinical and environmental risk factors to assess airway inflammation and predict exacerbation risk in advance, enabling healthcare providers and patients to monitor chronic respiratory conditions and receive actionable biological data for disease management and prevention.
- Sector
- Healthcare
- HQ
- Lowell, MA, United States
- Founded
- 2013
- Employees
- 9
- Website
- mybiometry.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.